Bonus BioGroup Ltd.
BBIXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $77 | $51 | $152 |
| - Cash | $1 | $1 | $7 | $9 |
| + Debt | $10 | $10 | $10 | $11 |
| Enterprise Value | $9 | $86 | $54 | $153 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$5 | -$5 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$6 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.009 | -0.009 | -0.008 | -0.006 |
| % Growth | 0% | -13.8% | -33.3% | – |
| Operating Cash Flow | -$4 | -$4 | -$4 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$4 | -$4 | -$6 |